Our meta-regression suggests that, besides HDL-C (or other surrogate markers of HDL concentration, such as Apo A1), statin use should also be considered in the multivariate analysis on the link between PON-1 and CAD occurrence. Here, PON1 is linked to coronary artery disorder.